Literature DB >> 7690547

Stimulation of tyrosine phosphorylation and mitogen-activated-protein (MAP) kinase activity in human SH-SY5Y neuroblastoma cells by carbachol.

S Offermanns1, E Bombien, G Schultz.   

Abstract

Activation of the G-protein-coupled muscarinic (M3) receptor in human neuroblastoma SH-SY5Y cells is known to lead to phosphoinositol hydrolysis and noradrenaline release. In this study, the effect of carbachol on tyrosine phosphorylation and mitogen-activated protein (MAP) kinase activity in SH-SY5Y cells was examined. Carbachol concentration-dependently induced tyrosine phosphorylation of several proteins, including one of 42 kDa. This tyrosine-phosphorylated 42 kDa protein co-eluted from a Mono Q anion-exchange column with MAP kinase activity and with immunologically detected MAP kinase. Stimulation of tyrosine phosphorylation and activation of MAP kinase were also observed after incubation of cells with phorbol 12-myristate 13-acetate (PMA) and epidermal growth factor (EGF). Down-regulation or inhibition of protein kinase C (PKC) abolished the stimulatory effects of both carbachol and PMA on MAP kinase activity, whereas EGF-stimulated MAP kinase activity remained unaffected. Thus carbachol acting through the muscarinic (M3) receptor PKC-dependently induced tyrosine phosphorylation and activation of a 42 kDa MAP kinase in SH-SY5Y cells, whereas EGF-induced MAP kinase activation occurred independently of PKC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690547      PMCID: PMC1134489          DOI: 10.1042/bj2940545

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

Review 1.  Mitogen-activated protein kinases: versatile transducers for cell signaling.

Authors:  S L Pelech; J S Sanghera
Journal:  Trends Biochem Sci       Date:  1992-06       Impact factor: 13.807

Review 2.  Extracellular signal-regulated kinases: ERKs in progress.

Authors:  M H Cobb; T G Boulton; D J Robbins
Journal:  Cell Regul       Date:  1991-12

3.  Blood platelets express high levels of the pp60c-src-specific tyrosine kinase activity.

Authors:  A Golden; S P Nemeth; J S Brugge
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

Review 4.  Molecular properties of the muscarinic acetylcholine receptor.

Authors:  N M Nathanson
Journal:  Annu Rev Neurosci       Date:  1987       Impact factor: 12.449

5.  The enzymatic preparation of [alpha-32P]ATP, [alpha-32P]GTP, [32P]cAMP, and [32P]cGMP, and their use in the assay of adenylate and guanylate cyclases and cyclic nucleotide phosphodiesterases.

Authors:  R A Johnson; T F Walseth
Journal:  Adv Cyclic Nucleotide Res       Date:  1979

6.  Calcium-dependent increase in tyrosine kinase activity stimulated by angiotensin II.

Authors:  W R Huckle; R C Dy; H S Earp
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

7.  Raf-1 activates MAP kinase-kinase.

Authors:  J M Kyriakis; H App; X F Zhang; P Banerjee; D L Brautigan; U R Rapp; J Avruch
Journal:  Nature       Date:  1992-07-30       Impact factor: 49.962

8.  pp60c-src is developmentally regulated in the neural retina.

Authors:  L K Sorge; B T Levy; P F Maness
Journal:  Cell       Date:  1984-02       Impact factor: 41.582

9.  Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine.

Authors:  M P Kamps; B M Sefton
Journal:  Oncogene       Date:  1988-04       Impact factor: 9.867

10.  Protein kinase C remains functionally active during TPA induced neuronal differentiation of SH-SY5Y human neuroblastoma cells.

Authors:  V Parrow; E Nånberg; J Heikkilä; U Hammerling; S Påhlman
Journal:  J Cell Physiol       Date:  1992-09       Impact factor: 6.384

View more
  8 in total

1.  The catalytic domain limits the translocation of protein kinase C alpha in response to increases in Ca2+ and diacylglycerol.

Authors:  Arathi Raghunath; Mia Ling; Christer Larsson
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

2.  GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors.

Authors:  Lionel Moulédous; Carine Froment; Stéphanie Dauvillier; Odile Burlet-Schiltz; Jean-Marie Zajac; Catherine Mollereau
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

3.  The m3 muscarinic acetylcholine receptor is coupled to mitogen-activated protein kinase via protein kinase C and epidermal growth factor receptor kinase.

Authors:  B E Slack
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

4.  Signalling pathway leading to an activation of mitogen-activated protein kinase by stimulating M3 muscarinic receptor.

Authors:  J Y Kim; M S Yang; C D Oh; K T Kim; M J Ha; S S Kang; J S Chun
Journal:  Biochem J       Date:  1999-01-15       Impact factor: 3.857

5.  Tyrosine phosphorylation of paxillin and focal adhesion kinase by activation of muscarinic m3 receptors is dependent on integrin engagement by the extracellular matrix.

Authors:  B E Slack
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

6.  Balancing Arc synthesis, mRNA decay, and proteasomal degradation: maximal protein expression triggered by rapid eye movement sleep-like bursts of muscarinic cholinergic receptor stimulation.

Authors:  Jonathan Soulé; Maria Alme; Craig Myrum; Manja Schubert; Tambudzai Kanhema; Clive R Bramham
Journal:  J Biol Chem       Date:  2012-05-14       Impact factor: 5.157

7.  Thrombin induces Egr-1 expression in fibroblasts involving elevation of the intracellular Ca2+ concentration, phosphorylation of ERK and activation of ternary complex factor.

Authors:  Oliver G Rössler; Gerald Thiel
Journal:  BMC Mol Biol       Date:  2009-05-11       Impact factor: 2.946

8.  Regulation of cyclic AMP response-element binding-protein (CREB) by Gq/11-protein-coupled receptors in human SH-SY5Y neuroblastoma cells.

Authors:  Elizabeth M Rosethorne; Stefan R Nahorski; R A John Challiss
Journal:  Biochem Pharmacol       Date:  2007-10-22       Impact factor: 5.858

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.